Effects of the Clinical Application of Traditional, Complementary and Integrative Medicine (TCIM) Procedures During Inpatient Stays in Germany
- Conditions
- Chronic Disease
- Registration Number
- NCT07040475
- Lead Sponsor
- Charite University, Berlin, Germany
- Brief Summary
The aim of this healthcare research project is to evaluate the effects of routine inpatient TCIM (Traditional, Complementary and Integrative Medicine) care in Germany. The focus is on the TCIM centers at Immanuel Krankenhaus Berlin, Klinikum Bamberg und Evang. Kliniken Essen-Mitte, where inpatient TCIM therapies are to be systematically evaluated. This form of therapy, which is reimbursed by statutory health insurance providers (under certain conditions), is based on a combination of various evidence-based TCIM approaches. These include hyperthermia, exercise therapy, Mind-Body Medicine, phytotherapy, nutritional therapy, fasting therapy inter alia.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 2500
Not provided
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Short Form Health Survey - 12 Items (SF-12) Baseline, 3 months 0-100, higher scores indicate better health status.
- Secondary Outcome Measures
Name Time Method Short Form Health Survey - 12 Items (SF-12) Baseline, up to 14 days, 6 months, 12 months 0-100, higher scores indicate better health status.
EuroQol 5-Dimension 5-Level Baseline, up to 14 days, 3 months, 6 months, 12 months 0 (worst) to 1 (best), higher scores indicate better health-related quality of life.
Food Frequency List Baseline, up to 14 days, 3 months, 6 months, 12 months Descriptive measure; not scored on a numeric scale.
International Physical Activity Questionnaire - Short Form Baseline, up to 14 days, 3 months, 6 months, 12 months MET-min/week (variable), higher scores indicate higher physical activity levels.
Hospital Anxiety and Depression Scale Baseline, up to 14 days, 3 months, 6 months, 12 months 0-21 per subscale (Anxiety and Depression), higher scores indicate more severe symptoms.
Work Productivity and Activity Impairment Questionnaire Baseline, 3 months, 6 months, 12 months 0%-100%, higher scores indicate greater impairment (i.e., worse outcome).
Perceived Stress Scale - 4 Baseline, up to 14 days, 3 months, 6 months, 12 months 0-16, higher scores indicate higher perceived stress.
Main complaint Baseline, up to 14 days, 3 months, 6 months, 12 months Visual Analog Scale (0-100, higher scores mean a worse outcome)
Fibromyalgia Impact Questionnaire Baseline, up to 14 days, 3 months, 6 months, 12 months 0-100, higher scores indicate greater impact of fibromyalgia (worse outcome).
Rheumatoid Arthritis Disease Activity Index Baseline, up to 14 days, 3 months, 6 months, 12 months 0-10, higher scores indicate greater disease activity (worse outcome).
Bath Ankylosing Spondylitis Disease Activity Index Baseline, up to 14 days, 3 months, 6 months, 12 months 0-10, higher scores indicate more active disease (worse outcome).
Bath Ankylosing Spondylitis Functional Index Baseline, up to 14 days, 3 months, 6 months, 12 months 0-10, higher scores indicate more functional limitation (worse outcome).
Western Ontario and McMaster Universities Osteoarthritis Index Baseline, up to 14 days, 3 months, 6 months, 12 months 0-100, higher scores indicate greater pain/stiffness/disability (worse outcome).
Irritable Bowel Syndrome Symptom Severity Score Baseline, up to 14 days, 3 months, 6 months, 12 months 0-500, higher scores indicate more severe IBS symptoms (worse outcome).
Short Inflammatory Bowel Disease Questionnaire Baseline, up to 14 days, 3 months, 6 months, 12 months 10-70, higher scores indicate better quality of life.
Pain Disability Index Baseline, up to 14 days, 3 months, 6 months, 12 months 0-70, higher scores indicate greater disability (worse outcome).
Roland Morris Disability Questionnaire Baseline, up to 14 days, 3 months, 6 months, 12 months 0-24, higher scores indicate more severe disability (worse outcome).
Maslach Burnout Inventory Baseline, up to 14 days, 3 months, 6 months, 12 months Variable by subscale (Emotional Exhaustion: 0-54, Depersonalization: 0-30, Personal Accomplishment: 0-48) Higher scores on EE/DP = worse outcome; higher PA = better outcome.
Beck Depression Inventory-II Baseline, up to 14 days, 3 months, 6 months, 12 months 0-63, higher scores indicate more severe depressive symptoms (worse outcome).
Diabetes Distress Scale - 17 Baseline, up to 14 days, 3 months, 6 months, 12 months 1-6, higher scores indicate greater emotional distress related to diabetes (worse outcome).
Dermatology Life Quality Index Baseline, up to 14 days, 3 months, 6 months, 12 months 0-30, higher scores indicate greater impact on quality of life (worse outcome).
Functional Assessment of Cancer Therapy - General Baseline, up to 14 days, 3 months, 6 months, 12 months 0-108, higher scores indicate better quality of life.
Use of the healthcare system Baseline,12 months Descriptive data (e.g., number of visits); not a scored scale.
Expectations regarding inpatient TCIM treatment Baseline 5-point Likert scale, 1-5. Higher scores indicate stronger or more positive expectations.
Chalder Fatigue Scale Baseline, up to 14 days, 3 months, 6 months, 12 months 0-33, higher scores mean a worse outcome
Somatic Symptom Scale Baseline, up to 14 days, 3 months, 6 months, 12 months 0-32, higher scores mean a worse outcome
Body weight [kg] Baseline, up to 14 days Height [in cm] Baseline BMI [kg/m2] Baseline, up to 14 days Systolic blood pressure [mmHg], diastolic blood pressure [mmHg] Baseline, up to 14 days Waist circumference [in cm] Baseline, up to 14 days Triglycerides [mg/dl] Baseline, up to 14 days Total cholesterol [mg/dl] Baseline, up to 14 days HDL [mg/dl] Baseline, up to 14 days LDL [mg/dl] Baseline, up to 14 days Glucose [mg/dl] Baseline, up to 14 days Uric acid [μmol/L] Baseline, up to 14 days Creatinine [mg/dl] Baseline, up to 14 days CRP [mg/l] Baseline, up to 14 days GPT [U/l] Baseline, up to 14 days HbA1c [mmol/mol] Baseline, up to 14 days HbA1c [%] Baseline, up to 14 days
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (3)
Sozialstiftung Bamberg, Klinikum Bamberg
🇩🇪Bamberg, Germany
Charité Hochschulambulanz für Naturheilkunde am Immanuel Krankenhaus, Institut für Sozialmedizin, Epidemiologie und Gesundheitsökonomie, Charité - Universitätsmedizin Berlin
🇩🇪Berlin, Germany
Klinik für Naturheilkunde und Integrative Medizin, KEM
🇩🇪Essen, Germany
Sozialstiftung Bamberg, Klinikum Bamberg🇩🇪Bamberg, GermanyJost Langhorst, Prof. Dr.Contact